Companies
Companies
AstraZeneca’s $300M Expansion Ignites Cell and Gene Therapy Revolution
AstraZeneca invests $300m in new research facility in Cambridge, UK to advance cell and gene therapies. 💉🔬💼🔍👥
Jazz Pharma Pays $10 Million for Cancer Treatment Breakthrough
🎯 Jazz Pharmaceuticals secures KRAS blockers from Redx Pharma 💰 $10M upfront, up to $870M milestones 💊 Enhancing cancer treatment options.
Spanish Plant-Based Protein Producer Raises €40m in Funding
🌱 Spanish plant-based protein producer Heüra Foods secures €40m in Series B funding to expand distribution and fuel growth. 🌍🚀
Novo Holdings Acquires Catalent for $165B Sells Sites for $11B: Tapping into Obesity and Diabetes Drug Market
📢 Novo Holdings acquires Catalent for $16.5B 💰 and sells 3 sites to Novo Nordisk for $11B 💼 to meet demand for obesity and diabetes drugs.
Major Leadership Changes in Biotech Industry: Stay Informed!
📰 Big changes in biotech! Cytomos, Sanofi, and Maxion shake up leadership. Exciting times ahead! 🧪🏭💼 Stay informed! 🌐💡
Novo Holdings Acquires Catalent for $165bn: Expanding Presence in Pharma Manufacturing
📢 Novo Holdings acquires CDMO Catalent for $16.5bn, expanding their presence in pharmaceutical manufacturing and development. 💼💉🌍
Novo Holdings Invests $165bn in CDMO Catalent Fueling Biotech Growth
🔍 Novo Holdings buys CDMO Catalent for $16.5bn, aiming to support its expansion in the CDMO market. 🏢💼📈
Serum Institute of India Joins CEPI to Fight ‘Disease X’
📰 Serum Institute of India joins CEPI to prepare against 'Disease X'. CEPI will fund vaccine development. 💉🌍😷🤝
Revolutionary Gut-on-Chip Tech: Transforming Biologic Drug Testing
🔍 Vivtex and Astellas team up to create oral biologic Gut-on-Chip tech, revolutionizing drug testing and therapy development. 💊🧪
Powerhouse Partnership Forms Europe’s Top Biologics CDMO
🔬💪 Biovian and 3P Biopharmaceuticals team up to form 3PBIOVIAN, a pan-European biologics CDMO with full development and manufacturing capabilities.
